跳至主要内容
临床试验/JPRN-UMIN000018852
JPRN-UMIN000018852已完成未知

Efficacy and safety of Antithrombin III administration for the patients with blood coagulation disorder after hepatectomy. - Efficacy and safety of Antithrombin III administration for the patients with blood coagulation disorder after hepatectomy.

Gasroenterological Surgery, Hiroshima University Hospital0 个研究点目标入组 140 人开始时间: 2015年9月20日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Clinically significant allergy 2. Clinically significant postoperative liver failure (T.Bil >=5.0mg/dL) 3. Clinically significant postoperative complication 4. Significant lack of antithrombin III (<30%) 5. Splenectomy 6. Presence of anastomosis of alimentary or biliary truct 7. Presence of biliary drainage 8. Clinically significant coagulopathy, renal disfunction or infection 9. Presence of psychological disorder

研究者

发起方
Gasroenterological Surgery, Hiroshima University Hospital

相似试验